Overall market sentiment has been down on Ibio Inc (IBIO) stock lately. IBIO receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With IBIO Stock Today?
Ibio Inc (IBIO) stock is trading at $1.65 as of 10:37 AM on Wednesday, Jun 24, a gain of $0.17, or 11.9% from the previous closing price of $1.47. The stock has traded between $1.62 and $1.88 so far today. Volume today is elevated. So far 23,864,763 shares have traded compared to average volume of 11,046,366 shares.
To see the top 5 stocks in the Biotechnology industry click here.
More About Ibio Inc
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products.
